Pharmaceuticals and money -- elements in the debate over a cost-disclosure bill. (Photo: O.S. Fisher, Shutterstock)
An attempt to force drug makers to disclose their costs and profits for drugs that sell wholesale for more than $10,000 annually was derailed in the Legislature, facing strong opposition from an industry targeting similar measures in other states. The forces battling over the bill include some of the most powerful in California.
OPINION: Sadly as we witness the Affordable Care Act unfold, we’re seeing the exact opposite. We’re finding “mom and pop” small businesses – indeed, our leading job creators – not just marginalized, but much of the time left out of the discussion altogether.